Sign multi-billion dollar deal between Insilico Medicine and Eli Lilly
Insilico Medicine, listed in Hong Kong, has announced a strategic partnership with American company Eli Lilly to develop new drugs using artificial intelligence technologies. The deal could be worth up to $2.75 billion, with an initial payment of $115 million.